ArticleJNCI cancer spectrum2026

Cost-effectiveness of an artificial intelligence predictive model for guiding androgen deprivation therapy in intermediate-risk prostate cancer.

P Travis Courtney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.